4. Ageing changes
1. Forehead and glabella creases.
2. Ptosis of the lateral brow.
3. Redundant upper eyelid skin.
4. Hollowing of the upper orbit.
5. Lower eyelid laxity and wrinkles.
6. Lower eyelid bags.
7. Deepening of the nasojugal groove (Tear trough).
8. Ptosis of the malar tissues.
9. Generalized skin laxity.
10. Deepening of nasolabial folds.
11. Perioral wrinkles.
12. Downturn of oral commissures.
13. Deepening of labiomental crease
14. Jowls.
15. Loss of neck definition and excess fat in neck.
16. Platysmal bands
5. CUTANEOUS FEATURES OF INTRINSIC
AND EXTRINSIC AGEING
INTRINSIC AGEING EXTRINSIC AGEING
Thinning of dermis, stratum corneum
normal, loss of rete ridges
Epidermal hyperplasia
Dermal atrophy with reduction of
collagen and elastin
Thickening Of the dermis & abnormal
elastin fibers leading to coarse dry skin
Atrophy of subcutaneous fat Decrease in collagen fibres and increase
in ground substances skin laxity and
wrinkles
Atrophy of hair follicles and loss of
melanocytes
Pigmentary changes like solar lentigenes
Decrease in linear nail growth
Decrease in number and function of
sweat glands
11. chemical peel
Accelerating Exfoliation by using irritant
chemicals
Classified - According to
the level of their injury
• Superficial
• Medium-depth
• Deep
12. SUPERFICIAL
VERY LIGHT
PEELS
Depth of
penetration-
limited to st.
corneum and
only creates
exfoliation
SUPERFICIAL
LIGHT PEEL
Depth of
penetration-
entire
epidermis
down to the
basal layer,
stimulating
regeneration
of fresh new
epithelium
MEDIUM
DEPTH PEELS
Depth of
penetration -
entire
epidermis
and papillary
dermis.
DEEP PEELS
Depth of
penetration-
papillary
dermis , into
the upper-
reticular
dermis and
may extend
to mid –
reticular
dermis
CLASSIFICATION OF PEELS
13. SUPERFICIAL VERY LIGHT PEELS
AHAs
10-15%
TCA
Tretinoin
Salicylic
acid
SUPERFICIAL LIGHT PEEL
1. 70% glycolic acid
J e s s n e r ’ s solution
(resorcinol + salicylic
acid + lactic acid +
ethanol)
2. 20-30% T C A
MEDIUM DEPTH PEELS
35% TCA
Jessner’s +
35% TCA
70% glycolic
acid + 35%
TCA
DEEP PEELS
TCA > 50%
Phenol
containing
preparation
14. AHAs
• Most commonly performed; being safe and non-toxic
naturally occurring compounds
• Glycolic acid is derived from sugar cane
• Lactic acid from sour milk
• Citric acid from citrus fruits
• Phytic acid from rice
• Depth of injury depends on : conc. of free acid, volume
applied, and duration of contact
15. Glycolic Acid
• Most popular & commonly used AHA
• Present in various conc. up to 70%
• Stable for more than two years
• Time of application is critical should be rinsed off with
5% sodium bicarbonate within 2-4 min.
• Can be used weekly for tt. of acne, mild
photoaging & melasma
16. AHAs
• Low conc. decrease the cohesion of
corneocytes at junction of st. corneum &
st. granulosum
• Higher conc. induce complete
epidermolysis
• Daily use of products containing AHA
results in increase
* skin thickness
* density of collagen
* improvement of elastic fiber quality
• Efficient For Treatment of Photoaging
17. BHA
• Salicylic acid (SA) is a BHA; used alone or in
Jessner's solution
• BHA has a stronger comedolytic effect than AHA
• Comedonal acne ; lipophylic & concentrates in
pilosebaceous unit and exfoliates the pores
18. Jessner’s Solution
• Combination of keratolytic ingredients (resorcinol
+ salicylic acid + lactic acid + ethanol)
• Inflammatory & comedonal acne (resorcinol)
• Rosacea (SA)
• Intense keratolytic activity induces loss of
corneocyte cohesion within the st. corneum
• Can be used with other peels because it does
not need neutralization
19. Trichloroacetic Acid Peels
• Different concentrations: 10-35%
• 10-15% TCA: intra epidermal superficial peel.
Improves fine wrinkles and dyschromias to give
smooth healthy appearance
• 30-35% TCA: papillary dermis, medium depth
peel.
Produce epidermal & dermal necrosis
• Be cautious with dark skin. (risk of PIH)
20. TC A
• Not light or heat-sensitive
• Stable for about 6 months
• No need for neutralization
• The clinical end point of tt. is frosting
• Frosting is due to denaturation of proteins
• Frosting appears within 7sec up to 20min
according to the conc. used
• Healing time within a week if used alone , 10
days if used in combination
22. END POINT
• *Minimal erythema +shiny skin--- VL
superficial peel
• *Erythema + streaky frosting------ Superficial
peel
• *Erythema+ level I or II frosting----Medium-
depth peel
23. Phenol Deep Peel
Baker’s Formula
• Pure undiluted 88% phenol + croton oil + septisol
liquid soap + water
24. INDICATIONS
DEPTH OF PEEL INDICATION
VERY SUPERFICIAL Skin glow, Comedonal acne
SUPERFICIAL Dyschromasia, melasma, PIH, Dilated
pores, fine wrinkles, photoageing I
MEDIUM DEPTH Fine wrinkles and photoageing II
DEEP PEELS Deep wrinkles and skin laxity
26. MICRODERMABRASION (MDA)
• Introduced by Marini and Lobrutto in 1985
• Types –
– Crystal MDA – mildly abrasive – Uses crystals (
Aluminium oxide)
– Diamond MDA – Used for deeper scars
27. MDA – Mechanism of action
• Gentle mechanical abrasion Removal of
stratum corneum.
• Also has effect on deeper layers of epidermis and
dermis
– Causes rearrangement of melanosomes in basal layer
– Flattening of rete ridges at DEJ
– Increases collagen fiber density
– Increases transdermal delivery hence MDA
combined with superficial skin peels to enhance
delivery
29. End point of treatment
• Pin point bleeding and effacement of rhytides
30. INDICATIONS
• Skin rejuvenation – improves skin tone and
texture
• Fine wrinkles
• Scars/acne scars
• Photoageing
• Striae
• Melasma
• Very effective in vertical peri-oral rhytides
31. CONTRAINDICATIONS
• Any bacterial or viral infections at the site
• Allergy to aluminium crystals (use different
crystal/diamond MDA)
• Relative contraindications
– Hypertrophic scars & keloids
32. Limitations of MDA
• Not useful for deep wrinkles, scars or PIH
• Use in melasma is controvertial
• Use with caution in Dark skin people (PIH)
34. LASERS IN FACIAL REJUVENATION
• Light Amplification by Stimulate Emissionof Radiation
• Characteristics: 1)Monochromaticity (samewave length)
2)Coherence- (in same phase - time
and space
3)Collimation-wavesremain parallel
39. Common Lasers in Plastic Surgery
Medium Laser Wavelength
(nm)
Target Chromophore
Gas Argon 488, 514 Oxyhemoglobin, Melanin
Carbondioxide 10,600 Water
40. LASER OUTPUT
⚫ CONTINUOUS MODE- co2 LASER
⚫PULSED MODE- pulseduration in microsecond
⚫QUALITY SWITCHING- pulse duration in
nanoseconds with extremely high peak power
42. CO2 LASER - 10,600nm
• Infrared invisible LASER
• Target chromophore : water
• Penetration <1 mm
• USES: Focused Mode-skin tags, warts moles
Defocused Mode-skin resurfacing,acnescars,
43. Nd:YAG LASER -1064nm
⚫Infrared invisible LASER in which medium is Nd
in a crystal of YAG.
pigments
⚫Target chromophore:
⚫ Penetration -10-20mm
vessel- 3 mm
⚫USES: tattoo marks
pigmented skin lesions
vascular lesions
44. Er:YAG - 2940nm
⚫Infrared invisible laser
⚫Targetchromophore: water
⚫Tissue penetration less thanco2 laser
⚫USES: skin resurfacing
45. Laser Resurfacing
• Ablation of abnormalities in the epidermis and upper dermis
and stimulation of dermal collagen remodelling diminishing
the effects of photoaging on skin, using a laser.
• CO2 laser Er: YAG laser
• Ideal candidates: Fair skin of Fitzpatrick I- III
: Fine to moderate facial wrinkles
47. Laser Resurfacing
Absolute contraindications
• Delayed wound healing
Active/ recent use of isotretinoin
History of burns/ SSGs
History of radiation treatment
Relative contraindications
• Fitzpatrick IV-VI
• Active Herpes Simplex
• Sensitive skin
48. Laser Resurfacing- Tissue Interactions
• Water Heat
• Complete ablation of epidermis (90% water)
• Zone of vapourized/ ablated tissue & surrounding thermally damaged
tissue
• Remodelling in less thermally damaged tissue
– Dermal collagen shrinkage & shortening
– Dermal tightening
– Collagen Remodelling/ Elastin fibre proliferation
– Collagen deposition
49. DERMAL FILLERS
• Injectable preparations used for soft tissue
augmentation
• History:
– Dr Arnold Klein (1980) – for lip augmentation
(bovine collagen)
• Hyaluronic acid was approved in 2003
– Natural component of human skin
(glucosaminoglycan)
50. Hyaluronic acid
• HA molecule is identical across all species and
lacks protein component (no immunological
reaction)
• Chemically composed of repeating
disaccharide unit with cross linked hydroxyl
group that binds to water (creates volume,
1000x)
51. • FDA approved various types of HAs and
products like calcium hydroxyapatite, Poly L
lactic acid and polymethylmethacrylate for
dermal fillers.
52. CLASSIFICATION OF DERMAL FILLERS
Temporary (3–12 Months)
Replace collagen in the skin, which weakens with age
and loses its elasticity.
Collagen has three main sources—bovine, porcine
and human.
Bovine collagen (widely used) is very similar to the
human molecule (telopeptides removed)
Hyaluronic acid is the most commonly used Filler
material of this category.
53. SEMI-PERMANENT FILLERS
Semi-Permanent (1–5 Years)
Calcium hydroxyapatite (creates a stable
scaffold for soft tissues to grow)
Calcium hydroxyapatite may be injected into the
deep dermis (formation of non-scar-tissue
type of collagen that provides volume)
55. INDICATIONS
• Glabellar and Forehead
wrinkles
• Augmentation of
Nasolabial Fold
• Lip Augmentation
• Tear Trough Deformity
• Augmentation of cheek
volume
56. CONTRAINDICATIONS
• Scarring and collagen/connective tissue
disorders
• Infections—e.g.: Viral Herpes
• Pregnant or Lactating women
57. THREADS IN FACIAL REJUVANATION
• Minimally invasive cosmetic procedure,
utilises a biocompatible implant placed into
the deeper layers of face to predictably shift
and realign tissues in a predetermined
direction or vector.
• Introduced by Ruff (Durham) and sulamindze
(Moscow)
58. CLASSIFICATION
• Depending on the modality of their action
a. Redefinition of the facial contours—Barbed
threads
b. Induction of collagen production—Mono
PDO threads
59. • Permanent/Non-resorbable threads-
Polypropylene threads (Aptos threads,
Silhouette lift threads)
• Resorbable threads—Polydioxanone threads
(Alfa aqualift) and Poly-L Lactic acid
(silhouette soft threads)
• Can be anchored or free floating
• Barbed or non barbed
60. BARBED THREADS
• Unidirectional – eg contour thread
• Anchored to a fixed point (eg deep
temporal fascia)
• Bidirectional – eg aptos thread
• Stretch the skin because of their design
• Cogged – can be uni/bi/multi
• Lift towards the direction of entry
(tissues get entangled)
61. Mechanism of action
a. These barbs get entangled in the subcutaneous tissues and as the
thread is pulled backwards, the tissues get squeezed along the
barbs and stay there.
b. At Cellular level
Mechanical transduction happens when the threads
are placed in the tissues
Intracellular signals in the surrounding cells
(mechanical stresses)
metabolic responses results in cellular growth modulates
tissue morphology and architecture
65. MICRONEEDLING (PERCUTANEOUS
COLLAGEN INDUCTION)
• Orentreich & Orentriech
• Introduction of needles beneath a retracted
scar/wrinkle stimulates neocollagenesis
• It is a procedure involving superficial and
controlled puncturing using miniature needles
66. • Helps in collaged induction and dermal
remodeling without any damage to epidermis
• Also aids in transdermal delivery of
therapeutic drugs
67. MECHANISM OF ACTION
• Multiple microscopic wounds are made with
minimal superficial bleeding in dermis
Multiple
microscopic
wounds in
dermis
Sets up wound
healing cascade
+ release of
growth factors
Neovascularizati
on and neo
collagenesis by
migration of
fibroblasts
73. RADIOFREQUENCY DEVICES
• Non ablative
• MECH OF ACTION
– electrothermal energy to generate heat in tissues by
rapid movement of charged particles
– At a critical temp. of 65-76º it leads to collagen
denaturation and tissue contraction
74. • Depth of penetration ∝ 1/frequency
• Amount of collagenesis ∝ amount of heat
generated but beyond 65º it plateaus
downtime and complications
75. • The dissipated heat leads to formation of
coagulated columns in dermis
• Cellular infiltration, neo collagenesis,
neovascularization and remodeling occurs
• In contrast to laser devices here the
temperature gradient is inverse hence RF has
minimal downtime
78. INDICATION
• Rhytides, acne scars, cellulite & stretch marks
CONTRAINDICATION
• Active infections at the site
• Pacemaker
• Keloidal tendency
• Anticoagulants
• Epilepsy
79. DEVICES
• NON INSULATED NEEDLE
– Larger coagulum zone
– More downtime
– More PIH
– Increased epidermal
injury
INSULATED NEEDLE
Delivers energy only at
tip
80. DEPTH OF NEEDLE USED
• 0.5-1mm – Pore reduction
• 1.2mm – wrinkles
• 2-3.5mm – acne scars and stretch marks
• END POINT OF PROCEDURE
– Minimal punctate bleeding
84. INDICATION
• Superficial wrinkles – esp. periorbital and neck
rhytides
• Improves skin texture and tone
• Reduces healing time when combined with
other modalities and CO2 fraction laser.
CONTRAINDICATION
• Platelet dysfunction syndrome
• Chronic liver disease (debatable)
• Local systemic infections
• Anticoagulant use
• Relative C/I – corticosteroids/immunosuppression
85. Therapeutic PRP
• Concentration – 1 million per ml of platelet
concentration
• Method of preparation
• Around 30ml of blood
sample gives 3 to 5 ml
of PRP
• Activation by calcium
gluconate
86. • There are 4 major families:
• P-PRP - Pure Platelet-rich plasma without Leukocytes.
It has low-density fibrin network after activation.
liquid solutions or an activated gel form and can be injected.
P-PRP is commonly used aesthetic medicine.
• L-PRP - Leukocyte and PRP is a preparation with leukocytes in
it.
low-density fibrin network after activation.
liquid solutions or an activated gel form and can be
injected.
L-PRP is used in aesthetic medicine & trichology, etc.
87. • P-PRF - Pure Platelet-rich fibrin is a preparation without
leukocytes.
It has a high-density fibrin network and exists as a
strongly activated gel form.
It cannot be injected
commonly used in dentistry & maxillofacial surgery
today.
• L-PRF - Leukocyte and PRF is a preparation with
leukocytes.
It has a high density of fibrin network
strongly activated gel
It cannot be injected
used in implant dentistry, periodontal surgeries,
oral surgeries, treatment of skin wound ulcers.
88. USES
• PRP can be repeated at interval of 4-6 weeks
• Can be infected or can be used with micro
needling
• Reduces erythema, improves healing and
reduces downtime
COMPLICATIONS
• Bruising at the site
• Single case of skin necrosis at the site of
injection and blindness in one eye has been
reported
89. THANK YOU
• References
– Grabb and Smith's Plastic Surgery (7th Ed.)
– Plastic Surgery - Peter C. Neligan (Vol-2)
– Non-surgical Modalities of Facial Rejuvenation and
Aesthetics - Oral and Maxillofacial Surgery for the
Clinician
Editor's Notes
Forehead unit · Nasal unit · Upper and lower eyelid units · Cheek units · Upper lip unit · Lower lip unit · Mental unit
Isotretinoin use- normal activity of sebacoeus gland is not there, which causes inhibition of re-epithelialisation
Burns/ SSG- Adequate and normal adnexal structures may be absent.
Higher Fitzpatrick types- laser use can lead to hyperpigmentation
PDGF (platelet-derived growth factor)—embryonic development, cell proliferation, cell migration and angiogenesis.
TGF-β1 & β2 (transforming growth factor)—regulating and mediating processes at the cellular level, including cell proliferation, differentiation, motility, adhesion and apoptosis as well as causes wound healing and angiogenesis.
VEGF (vascular endothelial growth factor)—Chemotactic and mitogenic for endothelial cells, mediates angiogenesis.
EGF (epidermal growth factor)—Mediates angiogenesis, causes proliferation of fibroblasts, endothelial cells and keratinocytes.
HGF (hepatocyte growth factor)—Mediates regeneration.
FGF (fibroblast growth factor)—Mediates tissue organisation and regeneration.
FGF-9—Aids generation of new follicles.